Loading clinical trials...
Loading clinical trials...
Part 1: A Randomized Controlled Open-Label Study of CM4620 Injectable Emulsion (CM4620-IE) in Patients With Severe COVID-19 Pneumonia Part 2: A Randomized Double Blind, Placebo-Controlled Study of Auxora for the Treatment of Severe COVID-19 Pneumonia (CARDEA)
Conditions
Interventions
Auxora (Part 1)
Standard of Care (Part 1)
+2 more
Locations
17
United States
Long Beach Memorial
Long Beach, California, United States
University of Southern California / LA County
Los Angeles, California, United States
Sharp Memorial San Diego
San Diego, California, United States
National Jewish Health / St. Joseph's Hospital
Denver, Colorado, United States
Northwestern University
Chicago, Illinois, United States
Baton Rouge General
Baton Rouge, Louisiana, United States
Start Date
April 8, 2020
Primary Completion Date
June 28, 2021
Completion Date
July 30, 2021
Last Updated
September 18, 2025
NCT07409727
NCT07186933
NCT06169514
NCT06092008
NCT07298889
NCT06750536
Lead Sponsor
CalciMedica, Inc.
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions